Right-sized multi-product manufacturing for biologics

Originally delivered Mar 15, 2021
  • Type:
    Archived Webinar
  • Level:
  • PDHs:

Share This Post:

The COVID pandemic has emphasized the need for local, agile pharmaceutical manufacturing, particularly for biologics and vaccines. This webinar presents a disruptive approach to biologics manufacturing based on small-scale, modular manufacturing technologies, which could enable the regional production of protein-based therapeutics, vaccines, and reagents.


Laura Crowell

Laura Crowell is a Director in Integrated Process Development at Sunflower Therapeutics PBC, a biotech startup focused on dramatically reducing the time and cost to develop and manufacture biologics for patients around the world. In her current role, Laura oversees ongoing efforts to develop right-sized and efficient manufacturing approaches for protein-based therapeutics and vaccines using strain engineering, integrated process development, and automated multi-product facilities.

Laura received her Ph.D. (2020) and M.S. (2015) in Chemical Engineering from MIT and her B.S. (2014) in...Read more



Do you already own this?



AIChE Members Free
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $99.00
Webinar content is available with the kind permission of the author(s) solely for the purpose of furthering AIChE’s mission to educate, inform and improve the practice of professional chemical engineering. All other uses are forbidden without the express consent of the author(s).